Linda Odeshoo
AuthID: R-00G-5GK
1
TÃTULO: Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: The SWAN study (AI424-097) 48-week results Full Text
AUTORES: Jose Gatell; Dominique Salmon Ceron; Adriano Lazzarin; Eric Van Wijngaerden; Francisco Antunes ; Clifford Leen; Andrzej Horban; Victoria Wirtz; Linda Odeshoo; Monique Van den Dungen; Claudia Gruber; Emilio Ledesma;
PUBLICAÇÃO: 2007, FONTE: CLINICAL INFECTIOUS DISEASES, VOLUME: 44, NÚMERO: 11
AUTORES: Jose Gatell; Dominique Salmon Ceron; Adriano Lazzarin; Eric Van Wijngaerden; Francisco Antunes ; Clifford Leen; Andrzej Horban; Victoria Wirtz; Linda Odeshoo; Monique Van den Dungen; Claudia Gruber; Emilio Ledesma;
PUBLICAÇÃO: 2007, FONTE: CLINICAL INFECTIOUS DISEASES, VOLUME: 44, NÚMERO: 11
